Astec Lifesciences approves right issue worth ₹250 crore, shares gain for third straight day

Astec Lifesciences intends to raise up to ₹250 crore through the rights issue process. Record date for the rights issue, its entitlement ratio and other aspects of the rights issue will be determined at a later date. 

Leave a Reply

Your email address will not be published. Required fields are marked *